Evidence map›Paper›PMID 36037358›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

False-positive IRESes from

Christina Akirtava, Gemma E May, C Joel McManus

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Multi-gene Co-expression systems inSynthetic and systems biotechnology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Evaluating the reliability of tools for mRNA annotation and IRES studies.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christina AkirtavaDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213.ORCID 0000-0001-7587-2303
Gemma E MayDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213.ORCID 0000-0003-1583-2400
C Joel McManusDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213.ORCID 0000-0002-6605-2642
Carnegie Mellon University · US

Funding

Global analysis of uORF evolution and functionR01GM121895 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI MCMANUS, CHARLES JOEL · 2017 to 2021
$1.6M
NIGMS NIH HHS R01 GM121895
6 · The paper itself

Abstract

Hyperconserved genomic sequences have great promise for understanding core biological processes. It has been recently proposed that scores of hyperconserved 5' untranslated regions (UTRs), also known as transcript leaders (hTLs), encode internal ribosome entry sites (IRESes) that drive cap-independent translation, in part, via interactions with ribosome expansion segments. However, the direct functional significance of such interactions has not yet been definitively demonstrated. We provide evidence that the putative IRESes previously reported in Hox gene hTLs are rarely included in transcript leaders. Instead, these regions function independently as transcriptional promoters. In addition, we find the proposed RNA structure of the putative

Indexed as

5' Untranslated RegionsHomeodomain ProteinsInternal Ribosome Entry SitesRibosomesTranscription FactorsAnimalsBinding SitesMammalsPromoter Regions, GeneticProtein Biosynthesis5' Untranslated Regionshomeobox protein HOXA9Homeodomain ProteinsInternal Ribosome Entry SitesTranscription FactorsbicistronicHoxIREStranslationUTR

Identifiers

PMID36037358
PMCPMC9456764
OpenAlexW4293484770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.